DOI QR코드

DOI QR Code

Survival and Prognostic Factors of Different Sites of Head and Neck Cancer: An Analysis from Thailand

  • Pruegsanusak, Kowit (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Peeravut, Sumet (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Leelamanit, Vitoon (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Sinkijcharoenchai, Wattana (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Jongsatitpaiboon, Jaturong (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Phungrassami, Temsak (Department of Radiology, Faculty of Medicine, Prince of Songkla University) ;
  • Chuchart, Kanyarat (Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University) ;
  • Thongsuksai, Paramee (Department of Pathology, Faculty of Medicine, Prince of Songkla University)
  • Published : 2012.03.31

Abstract

Background: Head and neck cancers are prevalent in Thailand, in particular in the southern region of the country. However, survival with a large data set has not been reported. The purpose of the present study was to evaluate the survival figures and the prognostic factors in a cohort of patients treated in a university hospital located in the south of Thailand. Patients and Methods: Consecutive new cases of primary carcinoma of the oral cavity, oropharyx, hypopharynx and larynx, treated at Songklanagarind Hospital during 2002 to 2004, were analyzed. The 5-year overall survival rates were obtained by the Kaplan-Meier method. Prognostic factors were identified through multivariate Cox regression analysis. Results: A total 1,186 cases were analyzed. Two-thirds (66.6%) of the cases were at advanced stage (stage III & IV) at presentation. The five-year overall survivals for the whole cohort, oral cavity, oropharynx, hypopharynx and larynx were 24.1%, 25.91%, 19.2%, 13.4%, 38.0% respectively. Stage and treatment type were strong prognostic factors for all sites. An age ${\geq}$ 80 years was associated with poor survival in oral cavity and larynx cancer. Conclusions: The results revealed remarkably poor outcomes of the patients in the series, indicating a strong need to increase the proportion of early stage presentations and maximize the treatment efficacy to improving outcomes. Very old patients are of particular concern for treatment care of oral cavity and larynx cancer.

References

  1. Barzan L, Talamini R, Franchin G, et al (2002). Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998. Cancer, 95, 540-52. https://doi.org/10.1002/cncr.10682
  2. Carvalho AL, Nishimoto IN, Califano JA, et al (2005). Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer, 114, 806-16. https://doi.org/10.1002/ijc.20740
  3. Chen AY, Matson LK, Roberts D, et al (2001). The significance of comorbidity in advanced laryngeal cancer. Head Neck, 23, 566-72. https://doi.org/10.1002/hed.1079
  4. Clark JR, de Almeida J, Gilbert R, et al (2006). Primary and salvage (hypo)pharyngectomy: Analysis and outcome. Head Neck, 28, 671-7. https://doi.org/10.1002/hed.20428
  5. De Paula AM, Souza LR, Farias LC, et al (2009). Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol, 45, 777-82. https://doi.org/10.1016/j.oraloncology.2008.11.015
  6. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin 1, 61, 69-90. https://doi.org/10.3322/caac.20107
  7. Kerdpon D, Sriplung H (2001). Factors related to delay in diagnosis of oral squamous cell carcinoma in southern Thailand. Oral Oncol, 37, 127-31. https://doi.org/10.1016/S1368-8375(00)00072-5
  8. Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer in Thailand Vol. V, 2001-2003. Bangkok; 2010. p. 10.
  9. Le Tourneau C, Velten M, Jung GM, et al (2005). Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck, 27, 801-8. https://doi.org/10.1002/hed.20254
  10. Lybak S, Liavaag PG, Monge OR, et al (2011). Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma. Eur Arch Otorhinolaryngol, 268, 449-56. https://doi.org/10.1007/s00405-010-1344-6
  11. MacKenzie K, Savage SA, Birchall MA (2009). Processes and outcomes of head and neck cancer patients from geographically disparate regions of the UK. A comparison of Scottish and English cohorts. Eur J Surg Oncol, 35, 1113-8. https://doi.org/10.1016/j.ejso.2009.04.001
  12. Makitie AA, Pukkila M, Laranne J, et al (2006). Oropharyngeal carcinoma and its treatment in Finland between 1995-1999: a nationwide study. Eur Arch Otorhinolaryngol, 263, 139-43. https://doi.org/10.1007/s00405-005-0975-5
  13. Mohanti BK, Nachiappan P, Pandey RM, et al (2007). Analysis of 2167 head and neck cancer patients' management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol, 121, 49-56.
  14. Oken MM, Creech RH, Tormey DC, et al (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5, 649-55. https://doi.org/10.1097/00000421-198212000-00014
  15. Pericot J, Escribà JM, Valdés A, et al (2000). Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx. J Craniomaxillofac Surg, 28, 49-55. https://doi.org/10.1054/jcms.1999.0091
  16. Rusthoven K, Ballonoff A, Raben D, et al (2008). Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer, 112, 345-51. https://doi.org/10.1002/cncr.23183
  17. Singh B, Alfonso A, Sabin S, et al (2000). Poluri A, Shaha AR, Sundaram K, et al. Outcome differences in younger and older patients with laryngeal cancer: a retrospective case-control study. Am J Otolaryngol, 21, 92-7.
  18. Warnakulasuriya S, Mak V, Moller H (2007). Oral cancer survival in young people in South East England. Oral Oncol, 43, 982-6. https://doi.org/10.1016/j.oraloncology.2006.11.021
  19. Woolgar JA, Rogers S, Wesr CR, et al (1999). Survival and patterns of recurrence in 200 cancers patients treated by radical surgery and neck dissection. Oral Oncol, 35, 257-65. https://doi.org/10.1016/S1368-8375(98)00113-4
  20. Yeole BB, Ramanakumar AV, Sankaranarayanan R (2003). Survival from oral cancer in Mumbai (Bombay), India.. Cancer Causes Control, 14, 945-52. https://doi.org/10.1023/B:CACO.0000007965.61579.b2

Cited by

  1. Antiproliferative Effects of Celecoxib in Hep-2 Cells through Telomerase Inhibition and Induction of Apoptosis vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4919
  2. Prognostic Significance of Altered Blood and Tissue Glutathione Levels in Head and Neck Squamous Cell Carcinoma Cases vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7603
  3. Survival rates of patients with cancer of the lip, mouth and pharynx: a cohort study of 10 years vol.17, pp.3, 2014, https://doi.org/10.1590/1809-4503201400030009
  4. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma vol.37, pp.11, 2014, https://doi.org/10.1002/hed.23803
  5. Epidemiological Study of Laryngeal Carcinoma in Western Nepal vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6541
  6. Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7331
  7. Treatment Outcome for Head and Neck Squamous Cell Carcinoma in a Developing Country: University Malaya Medical Centre, Malaysia from 2003-2010 vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2903
  8. Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0160901
  9. Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2073-z
  10. Knowledge and Health Belief Attitudes of Oral Cancer and Its Screening Among At-Risk Southern Thai Muslims pp.1543-0154, 2016, https://doi.org/10.1007/s13187-016-1150-y
  11. Platelet to lymphocyte ratio and red cell distribution width as prognostic factors for survival and recurrence in patients with oral cancer vol.274, pp.11, 2017, https://doi.org/10.1007/s00405-017-4734-1
  12. Factors related to diagnostic delay of oral squamous cell carcinoma in southern Thailand: Revisited pp.1354523X, 2017, https://doi.org/10.1111/odi.12757
  13. Epidemiology of head and neck cancer in Thailand pp.17437555, 2017, https://doi.org/10.1111/ajco.12757
  14. Cost-utility analysis of the screening program for early oral cancer detection in Thailand vol.13, pp.11, 2018, https://doi.org/10.1371/journal.pone.0207442
  15. Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells pp.1354523X, 2018, https://doi.org/10.1111/odi.12944
  16. Oral and oropharyngeal cancer: epidemiology and survival analysis vol.16, pp.2, 2018, https://doi.org/10.1590/s1679-45082018ao4248